A to Z / Growth hormone
Sermorelin
Also known as GRF 1-29, Geref, GHRH(1-29).
What it is
Sermorelin is the first 29 amino acids of natural growth hormone releasing hormone: the shortest fragment that retains full activity. It was FDA-approved as Geref for diagnosing and treating growth hormone deficiency in children.{{CITE:fr-geref-2013}}
The manufacturer withdrew it from the US market in 2008.{{CITE:fr-geref-2013}} That withdrawal was commercial, not a safety action, a detail that is often misunderstood in both directions.{{CITE:fr-geref-2013}}{{CITE:fda-drugsfda-geref}}
Today it is the most commonly compounded growth hormone peptide in American anti-ageing clinics.
What the full entry covers
The book carries the rest of this entry:
- Where the research stands, with every claim cited
- What people commonly ask, and what the research shows so far
- Dosing in four labelled bands, described and not recommended
- Side effects, serious risks, cautions and interactions
- Questions to discuss with your doctor
- How it compares with Tesamorelin, CJC-1295 (with DAC), Mod GRF (1-29), Ipamorelin
Related entries
A certificate of analysis tells you what is in a vial. The evidence rating above tells you whether the compound has been shown to work in humans. Neither answers the other's question. How to read a certificate of analysis.
This page describes what is known and not known about Sermorelin. It is not medical advice and not a recommendation to use it.